SARS-CoV-2 seroprevalence in Portugal following the third epidemic wave: results of the second National Serological Survey (ISN2COVID-19)-Reference-Cited by-同舟云学术

SARS-CoV-2 seroprevalence in Portugal following the third epidemic wave: results of the second National Serological Survey (ISN2COVID-19)

Published:2022-01-13 Issue:6 Volume:54 Page:418-424
ISSN:2374-4235
Container-title:Infectious Diseases
language:en
Short-container-title:Infectious Diseases

Author:

Kislaya Irina¹^ORCID,Gonçalves Paulo²^ORCID,Gómez Verónica¹^ORCID,Gaio Vânia¹^ORCID,Roquette Rita¹^ORCID,Barreto Marta¹^ORCID,Sousa-Uva Mafalda¹^ORCID,Torres Ana Rita¹^ORCID,Santos Joana¹^ORCID,Matos Rita²,Manita Carla²,Almeida Santos João²^ORCID,Soeiro Sofia²,de Sousa Rita²^ORCID,Costa Inês²^ORCID,Verdasca Nuno²,Guiomar Raquel²^ORCID,Rodrigues Ana Paula¹^ORCID,

Affiliation:

1. Departamento de Epidemiologia, Instituto Nacional de Saúde Doutor Ricardo Jorge, Lisbon, Portugal

2. Departamento de Doenças Infeciosas, Instituto Nacional de Saúde Doutor Ricardo Jorge, Lisbon, Portugal

Publisher

Informa UK Limited

Subject

Infectious Diseases,Microbiology (medical),General Immunology and Microbiology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/23744235.2021.2025421

Reference21 articles.

1. Direção-Geral da Saúde. Norma 002/2021 de 30/01/2021. Campanha de Vacinação Contra a COVID-19. Lisboa; 2021.

2. Direção-Geral da Saúde. Relatório de vacinação. Semana 13; Lisboa: Direção-Geral da Saúde; 2021.

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serological screening in a large-scale municipal survey in Cascais, Portugal, during the first waves of the COVID-19 pandemic: lessons for future pandemic preparedness efforts;Frontiers in Public Health;2024-02-02

2. SARS‐CoV‐2 seroprevalence and vaccine coverage from August to November 2021: A nationally representative survey in Mexico;Journal of Medical Virology;2023-08

3. Long-term neurological complications in COVID-19 survivors: study protocol of a prospective cohort study (NeurodegCoV-19);BMJ Open;2023-07

4. National and regional prevalence of SARS-CoV-2 antibodies in primary and secondary school children in England: the School Infection Survey, a national open cohort study, November 2021SARS-CoV-2 antibody prevalence in school children;Journal of Infection;2023-04

5. Comparative Effectiveness of COVID-19 Vaccines in Preventing Infections and Disease Progression from SARS-CoV-2 Omicron BA.5 and BA.2, Portugal;Emerging Infectious Diseases;2023-03